American Journal of Cardiology
Volume 99, Issue 3 , Pages 364-368 , 1 February 2007

Outcome of Overlapping Heterogenous Drug-Eluting Stents and of Overlapping Drug-Eluting and Bare Metal Stents

Received 27 June 2006 ,Revised 10 August 2006 ,Accepted 10 August 2006.

References 

  1. Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, et al Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation. 2004;110:2498–2505
  2. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol. 2004;93:826–829
  3. Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, et al “Full metal jacket” (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J. 2005;150:994–999
  4. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol. 2005;45:1570–1573
  5. Popma JJ, Bashore TD. Qualitative and quantitative angiography. In:  Topol E editors. Textbook of Interventional Cardiology. Philadelphia: WB Saunders; 1994;p. 1052–1068
  6. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005;112:270–278
  7. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653–662
  8. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663–670
  9. Biondi-Zoccai GG, Lotrionte M, Abbate A, Valgimigli M, Testa L, Burzotta F, et al. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. Int J Cardiol. 2007;114:104–105
  10. Mondesire WH, Jian W, Zhang H, Ensor J, Hung MC, Mills GB, et al. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells. Clin Cancer Res. 2004;10:7031–7042

PII: S0002-9149(06)02064-9

doi: 10.1016/j.amjcard.2006.08.039

American Journal of Cardiology
Volume 99, Issue 3 , Pages 364-368 , 1 February 2007

Article Tools

* Image Usage & Resolution